Search

everythinglearnresearchcommunity

for

Search:↓

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Treat hair loss with medicine, continue indefinitely.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

A new gene mutation causes insulin resistance in a girl and her mother.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.